Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15-17, 2005

A. Giannetti, K. Thestrup-Pedersen, Alain Taïeb, Jon Hanifin, Kevin Cooper, Jan D. Bos, Genji Imokawa, Tim J. David, Johannes Ring, Carlo Gelmetti, Alexander Kapp, Masutaka Furue, Yves De Prost, Ulf Darsow, Thomas Werfel, David Atherton, Arnold P. Oranje

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The 4th Georg Rajka International Symposium on Atopic Dermatitis presented a comprehensive view of our current understanding and management of atopic dermatitis (AD). These proceedings highlight contributions related to the history of AD doctrines; genetic and epigenetic background; epidemiology; maturation of the immune system; infection and innate-adaptive immunity; epidermal inflammation, including neurogenic inflammation and pruritus; animal models; skin barrier; evidence-based therapy and education programs; prognostic and severity markers; and allergy testing. Several studies in animal models and human subjects point to impaired skin barrier function as a primary defect that facilitates the effect of environmental factors and immune dysregulation found in AD. The new frontier in AD therapy should, in the near future, reflect our better understanding of the skin barrier. The influence of environmental factors on the skin and other epithelial barriers in the perinatal period needs to be better understood to implement appropriate prevention programs.

Original languageEnglish (US)
Pages (from-to)378-390
Number of pages13
JournalJournal of Allergy and Clinical Immunology
Volume117
Issue number2
DOIs
StatePublished - Feb 2006

Fingerprint

Atopic Dermatitis
France
Skin
Animal Models
Neurogenic Inflammation
Immunologic Factors
Adaptive Immunity
Pruritus
Innate Immunity
Epigenomics
Immune System
Hypersensitivity
Epidemiology
History
Inflammation
Education
Therapeutics
Infection

Keywords

  • Atopic dermatitis
  • Child
  • Neonate
  • Skin barrier

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15-17, 2005. / Giannetti, A.; Thestrup-Pedersen, K.; Taïeb, Alain; Hanifin, Jon; Cooper, Kevin; Bos, Jan D.; Imokawa, Genji; David, Tim J.; Ring, Johannes; Gelmetti, Carlo; Kapp, Alexander; Furue, Masutaka; De Prost, Yves; Darsow, Ulf; Werfel, Thomas; Atherton, David; Oranje, Arnold P.

In: Journal of Allergy and Clinical Immunology, Vol. 117, No. 2, 02.2006, p. 378-390.

Research output: Contribution to journalArticle

Giannetti, A, Thestrup-Pedersen, K, Taïeb, A, Hanifin, J, Cooper, K, Bos, JD, Imokawa, G, David, TJ, Ring, J, Gelmetti, C, Kapp, A, Furue, M, De Prost, Y, Darsow, U, Werfel, T, Atherton, D & Oranje, AP 2006, 'Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15-17, 2005', Journal of Allergy and Clinical Immunology, vol. 117, no. 2, pp. 378-390. https://doi.org/10.1016/j.jaci.2005.11.038
Giannetti, A. ; Thestrup-Pedersen, K. ; Taïeb, Alain ; Hanifin, Jon ; Cooper, Kevin ; Bos, Jan D. ; Imokawa, Genji ; David, Tim J. ; Ring, Johannes ; Gelmetti, Carlo ; Kapp, Alexander ; Furue, Masutaka ; De Prost, Yves ; Darsow, Ulf ; Werfel, Thomas ; Atherton, David ; Oranje, Arnold P. / Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15-17, 2005. In: Journal of Allergy and Clinical Immunology. 2006 ; Vol. 117, No. 2. pp. 378-390.
@article{27c1d9eebad74a99a14a339fd005dd97,
title = "Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15-17, 2005",
abstract = "The 4th Georg Rajka International Symposium on Atopic Dermatitis presented a comprehensive view of our current understanding and management of atopic dermatitis (AD). These proceedings highlight contributions related to the history of AD doctrines; genetic and epigenetic background; epidemiology; maturation of the immune system; infection and innate-adaptive immunity; epidermal inflammation, including neurogenic inflammation and pruritus; animal models; skin barrier; evidence-based therapy and education programs; prognostic and severity markers; and allergy testing. Several studies in animal models and human subjects point to impaired skin barrier function as a primary defect that facilitates the effect of environmental factors and immune dysregulation found in AD. The new frontier in AD therapy should, in the near future, reflect our better understanding of the skin barrier. The influence of environmental factors on the skin and other epithelial barriers in the perinatal period needs to be better understood to implement appropriate prevention programs.",
keywords = "Atopic dermatitis, Child, Neonate, Skin barrier",
author = "A. Giannetti and K. Thestrup-Pedersen and Alain Ta{\"i}eb and Jon Hanifin and Kevin Cooper and Bos, {Jan D.} and Genji Imokawa and David, {Tim J.} and Johannes Ring and Carlo Gelmetti and Alexander Kapp and Masutaka Furue and {De Prost}, Yves and Ulf Darsow and Thomas Werfel and David Atherton and Oranje, {Arnold P.}",
year = "2006",
month = "2",
doi = "10.1016/j.jaci.2005.11.038",
language = "English (US)",
volume = "117",
pages = "378--390",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Proceedings of the 4th Georg Rajka International Symposium on Atopic Dermatitis, Arcachon, France, September 15-17, 2005

AU - Giannetti, A.

AU - Thestrup-Pedersen, K.

AU - Taïeb, Alain

AU - Hanifin, Jon

AU - Cooper, Kevin

AU - Bos, Jan D.

AU - Imokawa, Genji

AU - David, Tim J.

AU - Ring, Johannes

AU - Gelmetti, Carlo

AU - Kapp, Alexander

AU - Furue, Masutaka

AU - De Prost, Yves

AU - Darsow, Ulf

AU - Werfel, Thomas

AU - Atherton, David

AU - Oranje, Arnold P.

PY - 2006/2

Y1 - 2006/2

N2 - The 4th Georg Rajka International Symposium on Atopic Dermatitis presented a comprehensive view of our current understanding and management of atopic dermatitis (AD). These proceedings highlight contributions related to the history of AD doctrines; genetic and epigenetic background; epidemiology; maturation of the immune system; infection and innate-adaptive immunity; epidermal inflammation, including neurogenic inflammation and pruritus; animal models; skin barrier; evidence-based therapy and education programs; prognostic and severity markers; and allergy testing. Several studies in animal models and human subjects point to impaired skin barrier function as a primary defect that facilitates the effect of environmental factors and immune dysregulation found in AD. The new frontier in AD therapy should, in the near future, reflect our better understanding of the skin barrier. The influence of environmental factors on the skin and other epithelial barriers in the perinatal period needs to be better understood to implement appropriate prevention programs.

AB - The 4th Georg Rajka International Symposium on Atopic Dermatitis presented a comprehensive view of our current understanding and management of atopic dermatitis (AD). These proceedings highlight contributions related to the history of AD doctrines; genetic and epigenetic background; epidemiology; maturation of the immune system; infection and innate-adaptive immunity; epidermal inflammation, including neurogenic inflammation and pruritus; animal models; skin barrier; evidence-based therapy and education programs; prognostic and severity markers; and allergy testing. Several studies in animal models and human subjects point to impaired skin barrier function as a primary defect that facilitates the effect of environmental factors and immune dysregulation found in AD. The new frontier in AD therapy should, in the near future, reflect our better understanding of the skin barrier. The influence of environmental factors on the skin and other epithelial barriers in the perinatal period needs to be better understood to implement appropriate prevention programs.

KW - Atopic dermatitis

KW - Child

KW - Neonate

KW - Skin barrier

UR - http://www.scopus.com/inward/record.url?scp=31944433906&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=31944433906&partnerID=8YFLogxK

U2 - 10.1016/j.jaci.2005.11.038

DO - 10.1016/j.jaci.2005.11.038

M3 - Article

C2 - 16514773

AN - SCOPUS:31944433906

VL - 117

SP - 378

EP - 390

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

SN - 0091-6749

IS - 2

ER -